期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

儿童腺样体肥大致肺动脉高压二例并右心导管检查分析 被引量：2

下载PDF
导出
摘要 肺高血压（pulmonary hypertension,PH）是一类以肺血管阻力进行性升高为主要特征,并最终导致右心衰竭甚至死亡的恶性心血管疾病。2008年在美国Dana Point召开的世界卫生组织第4届PH研讨会上,对PH临床分类进行了重新修订。将PH分为5类,其中肺部疾病和（或）低氧所致的肺动脉高压属于PH的第3类[1],
作者 周红梅 尚小珂 Liang Zhong 彭婷 邓晓娴 张刚成
机构地区 武汉亚洲心脏病医院先心病中心 国家肺动脉高压诊疗基地 国家结构心脏病介入培训基地 新加坡国立心脏中心 新加坡国立心脏研究所 国立大学医学研究院生物研究所
出处 《中国介入心脏病学杂志》 2014年第11期738-740,共3页 Chinese Journal of Interventional Cardiology
基金 Duke-NUS-GCR/2013/0009 by the Goh Cardiovascular Research Grant Singapore Singhealth Foundation(SHF/FG408/2009)
关键词 儿童 腺样体肥大 肺动脉高压 右心导管检查
分类号 R541.3 [医药卫生—心血管疾病] R725.4 [医药卫生—儿科]
  • 相关文献

参考文献13

  • 1Hoeman DP, Reda G, Scan MS. World Health Organization Group Ⅲ pulmonary hypertension. Prog Cardiovasc Dis, 2012,55:119- 127.
  • 2Kennedy JD, Waters KA. Investigation and treatment of upper- airway obstruction: childhood sleep disorders I. Med J Aust, 2005,182:419-423.
  • 3Praud JP. Snoring in children: still many questions, only a few answers. Pediatr Pulmonol Suppl,2004,26:169-171.
  • 4徐保平,申昆玲,张亚梅,安嘉清.腺样体肥大儿童睡眠呼吸障碍的研究[J].实用儿科临床杂志,2003,18(2):111-113. 被引量：20
  • 5白蕾,颜平,荆志成.睡眠呼吸暂停综合征与肺高血压[J].医学与哲学（B）,2013,34(5):50-53. 被引量：10
  • 6Spinella F, Rosano L, Dicastro V, et al. Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1 alpha in ovarian carcinoma cells. J Biol Chem,2002,277 : 27850-27855.
  • 7Sajkov D, McEvoy RD. Obstructive sleep apnea and pulmonary hypertension. Ping Cardiovase Dis ,2009,51:363-370.
  • 8吕树铮,宋现涛.中国心导管室现况与规范化需求[J].中国介入心脏病学杂志,2007,15(5):243-245. 被引量：8
  • 9张刚成,周红梅,邓晓娴,尚小珂.特发性肺动脉高压61例临床分析[J].解放军医药杂志,2014,26(6):1-4. 被引量：10
  • 10Brown LM, Chen H, Halpern S, et al. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest,2011,140 : 19-26.

二级参考文献58

  • 1吕树铮,宋现涛,陈韵岱,陈欣,中国经皮冠状动脉介入治疗登记调查研究协作组.中国大陆2005年度经皮冠状动脉介入治疗登记调查研究结果初步分析[J].中华心血管病杂志,2006,34(11):966-970. 被引量：43
  • 2高润霖．中国冠心病介入治疗现状．中华医学论坛报，2003-11-20(2)．
  • 3Society for Cardiac Angiography and Interventions. Directory of Cardiac Catheterization Laboratories in the United States. 4th ed. Raleigh, North Carolina: Bethesda, 1996.
  • 4Sheldon WC. Trends in cardiac catheterization laboratories in the United States. Catheter Cardiovasc Interv 2001,53:40-45.
  • 5Bashore. ACC/SCA&I Export Consensus Document. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Export Consensus Document on Cardiac Catheterization Laboratory Standards: A Report of the American College of Cardiology Task Force on Clinical Export Consensus Documents. JACC, 2001,37:2170-2214.
  • 6West R, Ellis G, Brooks N, et al. Complications of diagnostic cardiac catheterisation: results from a confidential inquiry into cardiac catheter complications. Heart, 2006,92:810-814.
  • 7Johnson LW, Krone R. Cardiac catheterisation 1991 : a report of the Registry of the Society for Cardiac Angiography and Interventions. Cathet Cardiovasc Diagn , 1993,28:219-220.
  • 8Chandrasekar B, Doucet S, Bilodeau L, et al. Complications of cardiac catheterization in the current era: a single-center experience. Catheter Cardiovasc Interv, 2001,52:289-295.
  • 9Laskey WK, Wondrow M, Holmes DR. Variability in Fluoroscopic X-Ray Exposure in Contemporary Cardiac Catheterization Laboratories. J Am Coll Cardiol, 2006,48:1361-1364.
  • 10Rubin I.J. Primary pulmonary hypertension[J]. N Engl J Med,1997,336(2) :111-117.

共引文献41

同被引文献25

  • 1仇烨,郑宝群,吴北燕,盛小刚,林郁生,郭继忠.儿童支气管哮喘肺动脉压力与右心舒张功能的变化[J].中国当代儿科杂志,1999,1(5):271-273. 被引量：4
  • 2Ivy DD, Abman SH,Barst R J, et al. Pediatric pulmonary hyper- tension [ J ]. J Am Coll Cardiol, 2013,62 ( 25 Suppl ) : D117- 126.
  • 3Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension [ J ]. J Am Coil Cardiol,2013,62(25 Suppl) :D34-.41.
  • 4Fraisse A, Jais X, Schleich JM, et al. Characteristics and pro- spective 2-year follow-up of children with pulmonary medal hypertension in France [ J ]. Arch Cardiovasc Dis, 2010, 103 (2) :66-74.
  • 5Berger RM, Beghetti M, Humpl T, et al. Clinical features of paediatric pulmonaryhypertension: a registry study [ J ]. Lancet, 2012,379(9815) :537-546.
  • 6van Loon RL, Roofthooft MT, Hillege HL, et al. Pediatric pul- monary hypertension in the Netherlands: epidemiology and char- acterization during the period 1991 to 2005 [ J]. Circulation, 2011,124 (16) : 1755-1764.
  • 7Martha VF, Moreira Jda S, Martha AS, et al. Reversal of pulmo- nary hypertension in children after adenoidectomy or adenoton- sillectomyL J ]. Int J Pediatr Otorhinolaryngol, 2013,77 ( 2 ) : 237-240.
  • 8Javaheri S, Javaheri S, Javaheri A. Sleep apnea, heart failure, and pulmonary Hypertension [J]. Curr Heart Fail Rep,2013,10 (4) :315-320.
  • 9Said SI, Hamidi SA, Gonzalez Bosc L. Asthma and pulmonaryarterial hypertension:do they share a key mechanism of patho- genesis? [J]. Eur Respir J,2010,35(4) :730-734.
  • 10Kuo CS, Young LR. Interstitial lung disease in children [ J ]. Curr Opin Pediatr,2014,26(3) :320-327.

引证文献2

二级引证文献6

中国介入心脏病学杂志
2014年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部